Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 10,180 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 19,575 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 19,575 shares (grant or award)
  7. 4 Grant or award Director acquired 10,180 shares (grant or award)
  8. 4 Shares withheld for taxes EVP, Commercial gave up 11,723 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP and CFO gave up 8,444 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP, Scientific Strategy & CSO gave up 6,123 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 5,349 shares (to pay taxes)
  12. 4 Open-market sale Director sold 40,000 shares at $19.65 ($786,000)
  13. 5 Insider Annual Insider Trading Report
  14. 5 Insider Annual Insider Trading Report
  15. 5 Insider Annual Insider Trading Report
  16. 4 Open-market sale Director sold 6,696 shares at $23.00 ($154,008)
  17. 4 Open-market sale EVP, Commercial sold 20,000 shares at an average $22.72 ($454,300)
  18. 4 Open-market sale EVP, General Counsel & Sec sold 18,000 shares at $22.00 ($396,000)
  19. 4 Grant or award President and CEO acquired 270,415 shares (grant or award)
  20. 4 Grant or award EVP and CFO acquired 75,985 shares (grant or award)

Page 14 of 73 · 1,458 filings